Emily M. Leproust sold $919k of TWST
Chief Executive Officer at Twist Bioscience Corp. 4,548 shares at an average of $202.15, traded Oct 5, 2026, filed Oct 7, 2026.
Score components
- +25RoleCEO
- +24Trade size$919k at market
- 0Share of holdings soldSold 0.8% of holdings
- +15Cluster6 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001214659-26-012647, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | SOpen-market sale Common Stock10b5-1 | -1,840 | $200.44 | $369k | 565,468 | 4 d ago |
| Oct 5, 2026 | SOpen-market sale Common Stock10b5-1 | -481 | $201.26 | $97k | 564,987 | 4 d ago |
| Oct 5, 2026 | SOpen-market sale Common Stock10b5-1 | -1,017 | $202.32 | $206k | 563,970 | 4 d ago |
| Oct 5, 2026 | SOpen-market sale Common Stock10b5-1 | -432 | $203.61 | $88k | 563,538 | 4 d ago |
| Oct 5, 2026 | SOpen-market sale Common Stock10b5-1 | -290 | $204.80 | $59k | 563,248 | 4 d ago |
| Oct 5, 2026 | SOpen-market sale Common Stock10b5-1 | -297 | $205.78 | $61k | 562,951 | 4 d ago |
| Oct 5, 2026 | SOpen-market sale Common Stock10b5-1 | -146 | $206.84 | $30k | 562,805 | 4 d ago |
| Oct 5, 2026 | SOpen-market sale Common Stock10b5-1 | -45 | $207.46 | $9,336 | 562,760 | 4 d ago |
Related signals
Other insiders at Twist Bioscience Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | Twist Bioscience Corp | Dennis Cho See Remarks | $1.8M 9,514 shares | -13% | |
| 65Notable | Twist Bioscience Corp | Patrick John Finn President and COO | $4.9M 25,714 shares | -12% | |
| 55Moderate | Twist Bioscience Corp | Paula Green SVP of Human Resources | $1.9M 10,088 shares | -9% | |
| 62Notable | Twist Bioscience Corp | Adam Laponis Chief Financial Officer | $1.5M 8,057 shares | -7% | |
| 45Moderate | Twist Bioscience Corp | Emily M. Leproust Chief Executive Officer | $8.8M 46,391 shares | -8% | |
| 44Moderate | Twist Bioscience Corp | Robert F. Werner Chief Accounting Officer | $280k 1,482 shares | -3% | |
| 44Moderate | Twist Bioscience Corp | Emily M. Leproust Chief Executive Officer | $923k 5,203 shares | -1% | |
| 37Weak | Twist Bioscience Corp | Dennis Cho See Remarks | $58k 348 shares | -0% | |
| 37Weak | Twist Bioscience Corp | Paula Green SVP of Human Resources | $49k 294 shares | -0% | |
| 54Moderate | Twist Bioscience Corp | Emily M. Leproust Chief Executive Officer | $279k 1,687 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.